AS3MT

AS3MT

Arsenic (+3 oxidation state) methyltransferase, also known as AS3MT, is a human gene.cite web | title = Entrez Gene: AS3MT arsenic (+3 oxidation state) methyltransferase| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=57412| accessdate = ]

PBB_Summary
section_title =
summary_text =

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Hernández A, Xamena N, Sekaran C, "et al." |title=High arsenic metabolic efficiency in AS3MT287Thr allele carriers. |journal=Pharmacogenet. Genomics |volume=18 |issue= 4 |pages= 349-55 |year= |pmid= 18334919 |doi= 10.1097/FPC.0b013e3282f7f46b
*cite journal | author=Fujihara J, Kunito T, Agusa T, "et al." |title=Population differences in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene polymorphism detected by using genotyping method. |journal=Toxicol. Appl. Pharmacol. |volume=225 |issue= 3 |pages= 251-4 |year= 2008 |pmid= 17889916 |doi= 10.1016/j.taap.2007.08.010
*cite journal | author=Hernández A, Xamena N, Surrallés J, "et al." |title=Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. |journal=Mutat. Res. |volume=637 |issue= 1-2 |pages= 80-92 |year= 2008 |pmid= 17850829 |doi= 10.1016/j.mrfmmm.2007.07.004
*cite journal | author=Lindberg AL, Kumar R, Goessler W, "et al." |title=Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. |journal=Environ. Health Perspect. |volume=115 |issue= 7 |pages= 1081-6 |year= 2007 |pmid= 17637926 |doi= 10.1289/ehp.10026
*cite journal | author=Schläwicke Engström K, Broberg K, Concha G, "et al." |title=Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. |journal=Environ. Health Perspect. |volume=115 |issue= 4 |pages= 599-605 |year= 2007 |pmid= 17450230 |doi= 10.1289/ehp.9734
*cite journal | author=Meza M, Gandolfi AJ, Klimecki WT |title=Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction? |journal=Toxicol. Appl. Pharmacol. |volume=222 |issue= 3 |pages= 381-7 |year= 2007 |pmid= 17306849 |doi= 10.1016/j.taap.2006.12.018
*cite journal | author=Wood TC, Salavagionne OE, Mukherjee B, "et al." |title=Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. |journal=J. Biol. Chem. |volume=281 |issue= 11 |pages= 7364-73 |year= 2006 |pmid= 16407288 |doi= 10.1074/jbc.M512227200
*cite journal | author=Kimura K, Wakamatsu A, Suzuki Y, "et al." |title=Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. |journal=Genome Res. |volume=16 |issue= 1 |pages= 55-65 |year= 2006 |pmid= 16344560 |doi= 10.1101/gr.4039406
*cite journal | author=Meza MM, Yu L, Rodriguez YY, "et al." |title=Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. |journal=Environ. Health Perspect. |volume=113 |issue= 6 |pages= 775-81 |year= 2005 |pmid= 15929903 |doi=
*cite journal | author=Li J, Waters SB, Drobna Z, "et al." |title=Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype. |journal=Toxicol. Appl. Pharmacol. |volume=204 |issue= 2 |pages= 164-9 |year= 2005 |pmid= 15808521 |doi= 10.1016/j.taap.2004.12.002
*cite journal | author=Strausberg RL, Feingold EA, Grouse LH, "et al." |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899
*cite journal | author=Lin S, Shi Q, Nix FB, "et al." |title=A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. |journal=J. Biol. Chem. |volume=277 |issue= 13 |pages= 10795-803 |year= 2002 |pmid= 11790780 |doi= 10.1074/jbc.M110246200
*cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, "et al." |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149-56 |year= 1997 |pmid= 9373149 |doi=
*cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171-4 |year= 1994 |pmid= 8125298 |doi=

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes


Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”